share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股sec公告 ·  07/22 13:22
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer and director, Kewalramani Reshma, is set to sell 15,202 shares of common stock on 07/22/2024, with an aggregate market value of approximately $7,555,394. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on various dates ranging from 02/13/2023 to 02/24/2024. The total number of shares acquired through these transactions was 14,702. This planned sale follows a recent history of transactions over the past three months, where a total of 16,767 shares were sold for gross proceeds of $7,510,499.
Vertex Pharmaceuticals Inc. officer and director, Kewalramani Reshma, is set to sell 15,202 shares of common stock on 07/22/2024, with an aggregate market value of approximately $7,555,394. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on various dates ranging from 02/13/2023 to 02/24/2024. The total number of shares acquired through these transactions was 14,702. This planned sale follows a recent history of transactions over the past three months, where a total of 16,767 shares were sold for gross proceeds of $7,510,499.
Vertex Pharmaceuticals Inc. 的董事和高级职员Kewalramani Reshma计划于2024年7月22日卖出15,202股普通股,市值约为$7,555,394。这些普通股是作为发行人通过不同日期(2023年2月13日至2024年2月24日)限制性股票注入报酬的一部分而获得的。通过这些交易所获得的股票总数为14,702股。这次计划出售的行动,是接下来三个月内多次交易的最新一笔,之前共卖出16,767股,总收益为$7,510,499。
Vertex Pharmaceuticals Inc. 的董事和高级职员Kewalramani Reshma计划于2024年7月22日卖出15,202股普通股,市值约为$7,555,394。这些普通股是作为发行人通过不同日期(2023年2月13日至2024年2月24日)限制性股票注入报酬的一部分而获得的。通过这些交易所获得的股票总数为14,702股。这次计划出售的行动,是接下来三个月内多次交易的最新一笔,之前共卖出16,767股,总收益为$7,510,499。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息